JP2018533589A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533589A5 JP2018533589A5 JP2018522753A JP2018522753A JP2018533589A5 JP 2018533589 A5 JP2018533589 A5 JP 2018533589A5 JP 2018522753 A JP2018522753 A JP 2018522753A JP 2018522753 A JP2018522753 A JP 2018522753A JP 2018533589 A5 JP2018533589 A5 JP 2018533589A5
- Authority
- JP
- Japan
- Prior art keywords
- plasminogen
- subject
- drug
- days
- deficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562250235P | 2015-11-03 | 2015-11-03 | |
| US62/250,235 | 2015-11-03 | ||
| PCT/IB2016/001599 WO2017077380A1 (en) | 2015-11-03 | 2016-11-03 | Plasminogen replacement therapy for plasminogen-deficiency |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018533589A JP2018533589A (ja) | 2018-11-15 |
| JP2018533589A5 true JP2018533589A5 (enExample) | 2019-12-12 |
| JP6878423B2 JP6878423B2 (ja) | 2021-05-26 |
Family
ID=58661917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018522753A Active JP6878423B2 (ja) | 2015-11-03 | 2016-11-03 | プラスミノーゲン欠損症のためのプラスミノーゲン補充療法 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US11291711B2 (enExample) |
| EP (1) | EP3370760B1 (enExample) |
| JP (1) | JP6878423B2 (enExample) |
| KR (1) | KR102821400B1 (enExample) |
| CN (1) | CN108289935A (enExample) |
| AU (1) | AU2016347863B2 (enExample) |
| BR (1) | BR112018008965A8 (enExample) |
| CA (1) | CA3002915C (enExample) |
| DK (1) | DK3370760T3 (enExample) |
| ES (1) | ES3055824T3 (enExample) |
| FI (1) | FI3370760T3 (enExample) |
| HR (1) | HRP20251512T1 (enExample) |
| IL (1) | IL258913B (enExample) |
| LT (1) | LT3370760T (enExample) |
| MX (1) | MX2018005588A (enExample) |
| MY (1) | MY199581A (enExample) |
| PL (1) | PL3370760T3 (enExample) |
| PT (1) | PT3370760T (enExample) |
| RS (1) | RS67519B1 (enExample) |
| RU (1) | RU2736831C2 (enExample) |
| SI (1) | SI3370760T1 (enExample) |
| SM (1) | SMT202500451T1 (enExample) |
| TW (1) | TWI801331B (enExample) |
| WO (1) | WO2017077380A1 (enExample) |
| ZA (1) | ZA201802820B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201722464A (zh) * | 2015-11-10 | 2017-07-01 | 波麥堤克生化科學有限公司 | 用於傷口癒合之纖維蛋白溶酶原給藥方案 |
| WO2017101866A1 (zh) | 2015-12-18 | 2017-06-22 | 深圳瑞健生命科学研究院有限公司 | 一种用于预防或治疗急性及慢性血栓的方法 |
| EP3395354B1 (en) | 2015-12-18 | 2024-05-22 | Talengen International Limited | Plasminogen for use in treating diabetic nephropathy |
| WO2017101871A1 (zh) * | 2015-12-18 | 2017-06-22 | 深圳瑞健生命科学研究院有限公司 | 一种预防和治疗心血管病的新方法 |
| TWI653981B (zh) | 2015-12-18 | 2019-03-21 | 深圳瑞健生命科學硏究院有限公司 | Use of plasminogen for the preparation of a medicament for preventing or treating a condition associated with diabetic nerve injury |
| US12011455B2 (en) | 2016-03-17 | 2024-06-18 | Vanderbilt University | Enhancing plasmin activity to prevent soft tissue calcification |
| TWI677348B (zh) * | 2016-12-15 | 2019-11-21 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種改善心臟病變的方法 |
| TWI750189B (zh) * | 2016-12-15 | 2021-12-21 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種治療冠狀動脈粥樣硬化及其併發症的方法 |
| JP7213552B2 (ja) * | 2016-12-15 | 2023-01-27 | タレンゲン インターナショナル リミテッド | 肝の繊維化を予防及び治療するための方法 |
| WO2018107701A1 (zh) * | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种新的降血糖和提高糖耐量的药物 |
| JP7168990B2 (ja) | 2016-12-15 | 2022-11-10 | タレンゲン インターナショナル リミテッド | 肥満症を予防および治療するための方法および薬物 |
| CA3067890A1 (en) * | 2017-06-19 | 2018-12-27 | Talengen International Limited | Method for regulating and controling glp-1/glp-1r and drug |
| CN109125715A (zh) * | 2017-06-19 | 2019-01-04 | 深圳瑞健生命科学研究院有限公司 | 一种调控glp-1/glp-1r的方法和药物 |
| TWI868051B (zh) * | 2017-06-23 | 2025-01-01 | 美商波麥堤克生物治療股份有限公司 | 與pai-1過表現相關之病狀的纖維蛋白溶酶原治療 |
| CN113597313A (zh) * | 2019-01-24 | 2021-11-02 | 先觉药业咨询公司 | 用于治疗和预防微血栓形成的纤溶酶原 |
| EP3812772B1 (en) * | 2019-10-24 | 2025-02-19 | Hôpitaux Universitaires de Strasbourg (HUS) | Method for diagnosing fibrinolytic insufficiency related to neutrophil extracellular traps |
| US12497607B2 (en) | 2020-04-23 | 2025-12-16 | Previpharma Consulting Gmbh | Plasminogen for use in treating and preventing lung dysfunction |
| CN114354929A (zh) * | 2022-01-07 | 2022-04-15 | 南京鼓楼医院 | 一种用于监测人体纤溶状态的试剂盒及应用 |
| WO2025049724A1 (en) * | 2023-08-29 | 2025-03-06 | Board Of Regents Of The University Of Nebraska | Compositions and methods for treating pleural space infections and hemothorax |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2254316B1 (enExample) * | 1973-12-18 | 1977-04-22 | Choay Sa | |
| JP2764264B2 (ja) * | 1987-10-01 | 1998-06-11 | 株式会社ミドリ十字 | 線溶活性増強剤 |
| AT402367B (de) | 1990-10-11 | 1997-04-25 | Immuno Ag | Pharmazeutische zubereitung auf basis von lys-plasminogen |
| WO1994001128A1 (en) * | 1992-07-01 | 1994-01-20 | Beth Israel Hospital Boston | Enhancement of thrombolytic therapy with deglycosylated plasminogen |
| EP0682700A4 (en) * | 1993-02-05 | 1997-05-28 | Vascular Lab | USE OF UROKINASE-LIKE PLASMINOGEN ACTIVATORS IN THE INTERIOR OF PLATES FOR THE LONG-TERM INHIBITION OF THROMBOSE. |
| US20030224516A1 (en) * | 2002-06-03 | 2003-12-04 | Isis Pharmaceuticals Inc. | Antisense modulation of prox-1 expression |
| US7067492B2 (en) * | 2001-09-06 | 2006-06-27 | Omnio Ab | Method of promoting healing of a tympanic membrane perforation |
| US20050271636A1 (en) * | 2002-08-09 | 2005-12-08 | St. Jude Children's Research Hospital, Inc. | Diagnostic and therapeutic uses for prox 1 |
| GB0509438D0 (en) * | 2005-05-09 | 2005-06-15 | Prometic Biosciences Ltd | Affinity adsorbets for fibrinogen |
| CA2662101C (en) * | 2006-08-28 | 2015-07-07 | Omnio Healer Ab | Candidates against infection |
| AU2007290882B2 (en) * | 2006-08-28 | 2013-02-21 | Omnio Healer Ab | Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| NZ597452A (en) * | 2009-07-10 | 2013-10-25 | Thrombogenics Nv | Variants of plasminogen and plasmin |
| KR20130100290A (ko) * | 2010-08-30 | 2013-09-10 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법 |
| PY1577621A (es) * | 2014-12-19 | 2017-10-02 | Prometic Biotherapeutics Inc | Composicion farmaceutica que comprende plasminogeno y uso para el mismo |
| JP2019500426A (ja) * | 2015-12-18 | 2019-01-10 | タレンゲン インターナショナル リミティッドＴａｌｅｎｇｅｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｌｉｍｉｔｅｄ | 糖尿病網膜症を予防または治療するための方法 |
-
2016
- 2016-11-02 TW TW105135535A patent/TWI801331B/zh active
- 2016-11-03 US US15/771,454 patent/US11291711B2/en active Active
- 2016-11-03 SM SM20250451T patent/SMT202500451T1/it unknown
- 2016-11-03 PT PT168616829T patent/PT3370760T/pt unknown
- 2016-11-03 FI FIEP16861682.9T patent/FI3370760T3/fi active
- 2016-11-03 MY MYPI2018000585A patent/MY199581A/en unknown
- 2016-11-03 KR KR1020187015657A patent/KR102821400B1/ko active Active
- 2016-11-03 CA CA3002915A patent/CA3002915C/en active Active
- 2016-11-03 RU RU2018120182A patent/RU2736831C2/ru active
- 2016-11-03 DK DK16861682.9T patent/DK3370760T3/da active
- 2016-11-03 ES ES16861682T patent/ES3055824T3/es active Active
- 2016-11-03 EP EP16861682.9A patent/EP3370760B1/en active Active
- 2016-11-03 SI SI201631933T patent/SI3370760T1/sl unknown
- 2016-11-03 MX MX2018005588A patent/MX2018005588A/es unknown
- 2016-11-03 PL PL16861682.9T patent/PL3370760T3/pl unknown
- 2016-11-03 LT LTEPPCT/IB2016/001599T patent/LT3370760T/lt unknown
- 2016-11-03 HR HRP20251512TT patent/HRP20251512T1/hr unknown
- 2016-11-03 BR BR112018008965A patent/BR112018008965A8/pt not_active Application Discontinuation
- 2016-11-03 JP JP2018522753A patent/JP6878423B2/ja active Active
- 2016-11-03 RS RS20251224A patent/RS67519B1/sr unknown
- 2016-11-03 AU AU2016347863A patent/AU2016347863B2/en active Active
- 2016-11-03 WO PCT/IB2016/001599 patent/WO2017077380A1/en not_active Ceased
- 2016-11-03 CN CN201680067482.XA patent/CN108289935A/zh active Pending
-
2018
- 2018-04-24 IL IL258913A patent/IL258913B/en unknown
- 2018-04-26 ZA ZA2018/02820A patent/ZA201802820B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018120182A (ru) | Плазминоген-заместительная терапия при дефиците плазминогена | |
| EP2635269B1 (en) | A combination composition | |
| Kelly et al. | Beta-adrenergic agonists for acute, severe asthma | |
| Kumar et al. | The syndrome of irreversible acidosis after prolonged propofol infusion | |
| ES2971959T3 (es) | Terlipresina para el tratamiento de la ascitis debida a cirrosis hepática administrada como una infusión continua | |
| JP2013541583A5 (enExample) | ||
| AU2011274652B2 (en) | A combination composition comprising ibuprofen and paracetamol | |
| EP3393517B1 (en) | Acetylsalicylic acid for use in the treatment of moderate to severe influenza | |
| Fabi et al. | Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope | |
| JP2020531568A5 (enExample) | ||
| Kurachek et al. | Inadvertent intravenous administration of racemic epinephrine | |
| EP3906934B1 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| Walsh et al. | A pediatric case study of treprostinil overdose | |
| Brønstad et al. | Fatal propofol infusion syndrome in a young man with status epilepticus. | |
| Zhou et al. | anesthesia care by | |
| Graff et al. | Chloroquine Ingestion to Prevent SARS-CoV-2 Infection: A Report of Two Cases | |
| Hwang et al. | Serotonin syndrome induced by drug interaction of isoniazid and metoclopramide | |
| Aranda et al. | Biodistribution Of [f-18] Fdg-Labeled Adult Bone Marrow-Derived Mesenchymal Stromal Cells With Pet/ct Scan In An Ards Sheep Model | |
| Nagaraj | NEUROLEPTIC MALIGNANT SYNDROME IN A CHILD WITH ORGANOPHOSPHORUS POISONING | |
| Pavcnik-Arnol et al. | SEDATION WITH SEVOFLURANE DELIVERED BY THE ANESTHETIC CONSERVING DEVICE ANACONDA® IN THE PEDIATRIC INTENSIVE CARE UNIT | |
| Yamamoto et al. | Heart Rate Response to Intravenous Landiolol during Propofol Anesthesia | |
| Nagaraj | INTERMITTENT BOLUS REGIMEN OF PROPOFOL IN CHILDREN REQUIRING SEDATION FOR AMBULATORY MAGNETIC RESONANCE IMAGING (MRI) | |
| Haitsma et al. | Surfactant Therapy | |
| Aburawi | Epinephrine overdose | |
| Weiner | Valproic acid |